ロード中...
Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?
COVID-19 is characterized by predominant respiratory and gastrointestinal symptoms. Liver enzymes derangement is seen in 15–55% of the patients. Advanced age, hypertension, diabetes, obesity, malignancy, and cardiovascular disease predispose them to severe disease and the need for hospitalization. D...
保存先:
| 出版年: | J Clin Exp Hepatol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7774459/ https://ncbi.nlm.nih.gov/pubmed/33398223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2020.12.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|